Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126419591 | 12641959 | 1 | I | 20160719 | 20160801 | 20160810 | 20160810 | EXP | GB-MHRA-EYC 00142924 | GB-MYLANLABS-2016M1032316 | MYLAN | 0.00 | Y | 0.00000 | 20160810 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126419591 | 12641959 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 200 MG, QD | 200 | MG | Y | U | 62337 | 200 | MG | QD | |||
| 126419591 | 12641959 | 2 | SS | CARBOCISTEINE | CARBOCYSTEINE | 1 | Oral | 750 MG, TID | 2250 | MG | Y | U | 0 | 750 | MG | TID | |||
| 126419591 | 12641959 | 3 | C | ADCAL D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 4 | C | GAVISCON ADVANCE | POTASSIUM BICARBONATESODIUM ALGINATE | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 5 | C | LAXIDO /06401201/ | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 6 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 7 | C | LIDOCAINE. | LIDOCAINE | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 8 | C | MORPHINE | MORPHINE | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 10 | C | PARACETAMOL | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 11 | C | SALBUTAMOL | ALBUTEROL | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 12 | C | SENNA /00142201/ | SENNA LEAF | 1 | U | 0 | |||||||||||
| 126419591 | 12641959 | 13 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126419591 | 12641959 | 1 | Infective exacerbation of bronchiectasis |
| 126419591 | 12641959 | 2 | Increased viscosity of bronchial secretion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126419591 | 12641959 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126419591 | 12641959 | Dehydration | |
| 126419591 | 12641959 | Nausea | |
| 126419591 | 12641959 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126419591 | 12641959 | 1 | 20160719 | 20160721 | 0 | |
| 126419591 | 12641959 | 2 | 20160718 | 0 |